Shopping Cart
- Remove All
- Your shopping cart is currently empty
EMI56, a derivative of EMI1, exhibits enhanced potency against mutant EGFR compared to EMI1. Additionally, EMI56 effectively inhibits EGFR triple mutants[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $233 | 5 days | |
5 mg | $297 | 5 days | |
25 mg | $916 | 6-8 weeks | |
50 mg | $1,190 | 6-8 weeks | |
100 mg | $1,860 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $318 | 5 days |
Description | EMI56, a derivative of EMI1, exhibits enhanced potency against mutant EGFR compared to EMI1. Additionally, EMI56 effectively inhibits EGFR triple mutants[1]. |
In vitro | EMI56 inhibits EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S and can be used in research of mutant EGFR-associated, drug-resistant non-small-cell lung cancer (NSCLC)[1]. EMI56 (10, 15, 20 μM; 2 h of treatment) strongly inhibits total EGFR levels, activation, and downstream signaling in PC9 EGFR ex19del/T790M/C797S cells[1]. |
Molecular Weight | 348.4 |
Formula | C21H20N2O3 |
Cas No. | 2414374-41-5 |
Relative Density. | 1.259 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (143.51 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.